organoid Archives - Let's Win! Pancreatic Cancer

Lustgarten Foundation Advances Pancreatic Cancer Research Through Partnerships with the Opening of Two New Laboratories

The Lustgarten Foundation announces two new pancreatic cancer research laboratories through respective partnerships with Dana-Farber Cancer Institute and Massachusetts Institute of Technology (MIT).

Picking the Right Team

Brigitte Régnier found a treatment team that was using an unusual approach of giving chemoradiation before surgery for pancreatic cancer.

Organoids Accurately Predict Treatment Response of Pancreatic Cancer Patients

An international team of researchers led by Dr. David Tuveson has found that organoids can predict how pancreatic cancer patients will respond to different treatments.

Mechanism of Metastasis Is Discovered in Pancreatic Cancer

The Foundation’s dedicated lab at Cold Spring Harbor Laboratory (CSHL) used organoid technology to find that pancreatic cancer cells reprogram…

Discovery of Distinct Cell Subtypes Around Tumors Helps Explain Why Pancreatic Cancer is so Hard to Treat

With a median survival of only 6 months and a 5-year survival rate of about 8%, patients tend to be…

Dr. David Tuveson named Director, NCI-Designated Cancer Center at Cold Spring Harbor Laboratory

Dr. Stillman has served as director of the Laboratory’s National Cancer Institute (NCI)-designated Cancer Center for 25 years, shepherding the…

In shades of light brown, beige, and white, stalks of grasses against a tan background

Currently in the Fight, at Memorial Sloan Kettering Cancer Center

A woman's treatment for non-operable pancreatic cancer at Memorial Sloan Kettering includes FOLFIRINOX and stereotactic body radiation therapy.

Close up photo of microscope lenses over a slide, against a blue background

Novel Drug Therapy Kills Pancreatic Cancer Cells by Reducing Levels of Antioxidants

New research finds that reducing antioxidants can help kill pancreatic cancer cells, suggesting a new direction for treatment.